Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Revenue: 2019-2024

Historic Revenue for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $401.2 million.

  • Cellebrite DI's Revenue rose 17.94% to $126.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.9 million, marking a year-over-year increase of 18.37%. This contributed to the annual value of $401.2 million for FY2024, which is 23.41% up from last year.
  • Latest data reveals that Cellebrite DI reported Revenue of $401.2 million as of FY2024, which was up 23.41% from $325.1 million recorded in FY2023.
  • Cellebrite DI's Revenue's 5-year high stood at $401.2 million during FY2024, with a 5-year trough of $194.9 million in FY2020.
  • Its 3-year average for Revenue is $332.3 million, with a median of $325.1 million in 2023.
  • Data for Cellebrite DI's Revenue shows a peak YoY climbed of 26.34% (in 2021) over the last 5 years.
  • Over the past 5 years, Cellebrite DI's Revenue (Yearly) stood at $194.9 million in 2020, then grew by 26.34% to $246.2 million in 2021, then grew by 9.91% to $270.7 million in 2022, then grew by 20.12% to $325.1 million in 2023, then rose by 23.41% to $401.2 million in 2024.